Fosgerau, K, Skovgaard, M., Larsen, S.A., Bæk, C.Æ., Meier, E., Groendahl, C., and Bak, H.H.:
Combination of long-acting insulin with the dual GluGLP-1 agonist ZP2929 causes improved glycemic control without body weight gain in db/db mice
Poster at ADA 71st Scientific Sessions 2011, 24 – 28 June, 2011, San Diego, California, USA
Diabetes 2011, 60, Suppl 1, A418, Poster 1527-P
Poster
Davuluri, P., Abrar, M., Allanson, J. and Bæk, C.Æ.:
Development of a High Sensitivity On-Line extraction LC-MS/MS (Xevo TQ-S) method for the Determination of GLP-1-Glucagon agonist (ZP2929) in Human Plasma
EBF – European Bioanalysis Forum, Focus Meeting: “Large Meets Small”, June 21-22, 2011, Brussels, Belgium
Poster No. 17
Bæk, C.Æ., Jensen, A.L., Malik, N. and Hemsley, M.:
Bioanalytical methods using LC-MS/MS for determination of the GLP-1-Glu dual agonist ZP2929 in plasma
EBF – European Bioanalysis Forum, Focus Meeting: “Large Meets Small”, June 21-22, 2011, Brussels, Belgium
Poster No. 2
Daugaard, J.R., Meier, E., Riber, D., Bæk, C.Æ. and Larsen, K.:
The New Dual Glucagon-GLP-1 Agonist ZP2929 Acutely Improves Glycemic Control in High Fat Fed C57BL/6J Mice
Abstract for Keystone January 12 - January 17, 2011, Keystone, Colorado
Poster Number: 140, page 86 in abstract book.
Daugaard, J.R., Riber, D., Larsen, K., Meier, E., Bæk, C.Æ., Kampen, G.
The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and insulin resistance
Poster at EASD 46th Annual Meeting, Stockholm, Sweden, Sep. 20-24, 2010
Diabetologica, 2010, 53, Suppl 1, S354-S354
Poster
Daugaard, J.R., Meier, E., Riber, D., Bæk, C.Æ., Larsen, K., Kampen, G.:
The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and insulin Type 2 Diabetes.
The American Diabetes Association’s (ADA) 70th Scientific Sessions, 25-29 June, 2010, Orlando, FL, USA
Diabetes, 2010, 59, Suppl 1,1630-P, p A430
Poster
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 31.1.2012